Fate Therapeutics, Inc.
← Back to FATE Overview

Fate Therapeutics, Inc. (FATE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-0.90

Financial Fundamentals

FATEQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2012-09-30-3.57
2012-12-31-3.53
2013-03-31-4.14
2013-06-30-5.73
2013-09-30-5.22
2013-12-31-5.39
2014-03-31-7.10
2014-06-30-5.32
2014-09-30-3.96
2014-12-31-4.14
2015-03-31-3.19
2015-06-30-4.97
2015-09-30-5.54
2015-12-31-3.25
2016-03-31-1.55
2016-06-30-1.46
2016-09-30-2.86
2016-12-31-2.94
2017-03-31-4.65
2017-06-30-3.48
2017-09-30-3.84
2017-12-31-5.34
2018-03-31-9.11
2018-06-30-7.66
2018-09-30-13.12
2018-12-31-12.93
2019-03-31-14.42
2019-06-30-14.76
2019-09-30-9.77
2019-12-31-13.07
2020-03-31-12.57
2020-06-30-24.23
2020-09-30-14.79
2020-12-31-37.39
2021-03-31-42.71
2021-06-30-37.12
2021-09-30-32.64
2021-12-31-20.42
2022-03-31-14.22
2022-06-30-7.87
2022-09-30-6.50
2022-12-31-4.35
2023-03-31-7.40
2023-06-30-2.22
2023-09-30-1.16
2023-12-31-2.09
2024-03-31-3.73
2024-06-30-2.49
2024-09-30-2.16
2024-12-31-0.93
2025-03-31-0.62
2025-06-30-0.97
2025-09-30-1.16
2025-12-31-0.90

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.